by Biospring | Jul 14, 2023 | Artificial Intelligence, Automation, Data, LLM, Machine Learning, Synbio, Synthetic Biology
Florencio (Flo) Mazzoldi is the Head of Digital Technology at Ginkgo Bioworks, where he leads the development of the digital technologies that power Ginkgo’s foundries and Codebase. We are excited to dig into Florencio’s role and hear more about Ginkgo’s digital...
by Biospring | Nov 9, 2022 | Advisory Board, Biospring Partners
Biospring is pleased to announce the addition of two industry executives to its Advisory Board – Arnaub Chatterjee, SVP Product and Ecosystem at Medidata and Qi Wang, CIO Portfolio Implementation and Portfolio Manager at PIMCO. Biospring’s Advisors support the...
by Biospring | Aug 1, 2022 | Advanced Therapy, Biologics, Biomanufacturing, CDMO, Cell and Gene Therapy, CGT, Drug Development, Life Sciences Technology
For a biotech company, discovering a new therapeutic candidate is a years-long, herculean achievement. A crucial question post-discovery is, can the drug be manufactured at scale? Companies must ensure that they can procure enough of a new therapy for clinical trials...
by Biospring | May 30, 2022 | Curie Bio, EHR, Flatiron Health, Pharma, RWD, RWE, Zach Weinberg
Zach Weinberg is a Co-Founder of Curie Bio and Operator Partners. Zach was previously Co-Founder, President, and COO of both Flatiron Health (acquired by Roche in 2018 for $2B) and Invite Media (acquired by Google in 2010 for $81M). Zach is one of the most successful...
by Biospring | Apr 26, 2022 | Data Science, Digital Health, Drug Development, Drug Discovery, Janssen, Najat Khan
We were delighted to host a discussion with Najat Khan, PhD, Chief Data Science Officer and Global Head of Strategy and Operations, Janssen Research & Development (R&D), Johnson and Johnson. As the Chief Data Science Officer, Dr. Khan leads a team of 100+ data...
